Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

July 01, 1986; Volume 14,Issue 4
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Albert, A

    1. You have access
      Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes.
      P H Beaune, P G Kremers, L S Kaminsky, J De Graeve, A Albert and F P Guengerich
      Drug Metabolism and Disposition July 1986, 14 (4) 437-442;
  2. Andres, H H

    1. You have access
      N-acetylation pharmacogenetics. Michaelis-Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivo.
      H H Andres and W W Weber
      Drug Metabolism and Disposition July 1986, 14 (4) 382-385;

B

  1. Baba, S

    1. You have access
      Pharmacokinetic equivalence of deuterium-labeled and unlabeled phenytoin.
      K Mamada, Y Kasuya and S Baba
      Drug Metabolism and Disposition July 1986, 14 (4) 509-511;
  2. Baillie, T A

    1. You have access
      Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy, J S Lockard, K E Thummel and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 443-453;
    2. You have access
      Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 454-464;
  3. Barber, H E

    1. You have access
      Mechanism responsible for altered propranolol disposition in adjuvant-induced arthritis in the rat.
      K A Walker, H E Barber and G M Hawksworth
      Drug Metabolism and Disposition July 1986, 14 (4) 482-486;
  4. Barinov, I

    1. You have access
      Inhibition of ciramadol glucuronidation by benzodiazepines.
      R H Meacham, S F Sisenwine, A L Liu, C J Kick, I Barinov and H W Ruelius
      Drug Metabolism and Disposition July 1986, 14 (4) 430-436;
  5. Beaune, P H

    1. You have access
      Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes.
      P H Beaune, P G Kremers, L S Kaminsky, J De Graeve, A Albert and F P Guengerich
      Drug Metabolism and Disposition July 1986, 14 (4) 437-442;
  6. Benet, L Z

    1. You have access
      Characterization of the isomeric esters of zomepirac glucuronide by proton NMR.
      P C Smith and L Z Benet
      Drug Metabolism and Disposition July 1986, 14 (4) 503-505;
  7. Bickers, D R

    1. You have access
      Capsaicin as an in vitro inhibitor of benzo(a)pyrene metabolism and its DNA binding in human and murine keratinocytes.
      C E Modly, M Das, P S Don, C L Marcelo, H Mukhtar and D R Bickers
      Drug Metabolism and Disposition July 1986, 14 (4) 413-416;
  8. Birnbaum, L S

    1. You have access
      Age-related changes in the metabolism and excretion of allyl isothiocyanate. A model compound for glutathione conjugation.
      S J Borghoff and L S Birnbaum
      Drug Metabolism and Disposition July 1986, 14 (4) 417-422;
  9. Borghoff, S J

    1. You have access
      Age-related changes in the metabolism and excretion of allyl isothiocyanate. A model compound for glutathione conjugation.
      S J Borghoff and L S Birnbaum
      Drug Metabolism and Disposition July 1986, 14 (4) 417-422;
  10. Brammer, J D

    1. You have access
      Activation of 14C-toluene to covalently binding metabolites by rat liver microsomes.
      A Pathiratne, R L Puyear and J D Brammer
      Drug Metabolism and Disposition July 1986, 14 (4) 386-391;
  11. Bygdeman, M

    1. You have access
      Metabolism of 16, 16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester (ONO-802) following intravenous and vaginal administration to pregnant women.
      V Dimov, K Gréen, M Bygdeman and N J Christensen
      Drug Metabolism and Disposition July 1986, 14 (4) 494-502;

C

  1. Christensen, N J

    1. You have access
      Metabolism of 16, 16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester (ONO-802) following intravenous and vaginal administration to pregnant women.
      V Dimov, K Gréen, M Bygdeman and N J Christensen
      Drug Metabolism and Disposition July 1986, 14 (4) 494-502;

D

  1. Das, M

    1. You have access
      Capsaicin as an in vitro inhibitor of benzo(a)pyrene metabolism and its DNA binding in human and murine keratinocytes.
      C E Modly, M Das, P S Don, C L Marcelo, H Mukhtar and D R Bickers
      Drug Metabolism and Disposition July 1986, 14 (4) 413-416;
  2. De Graeve, J

    1. You have access
      Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes.
      P H Beaune, P G Kremers, L S Kaminsky, J De Graeve, A Albert and F P Guengerich
      Drug Metabolism and Disposition July 1986, 14 (4) 437-442;
  3. Dimov, V

    1. You have access
      Metabolism of 16, 16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester (ONO-802) following intravenous and vaginal administration to pregnant women.
      V Dimov, K Gréen, M Bygdeman and N J Christensen
      Drug Metabolism and Disposition July 1986, 14 (4) 494-502;
  4. Don, P S

    1. You have access
      Capsaicin as an in vitro inhibitor of benzo(a)pyrene metabolism and its DNA binding in human and murine keratinocytes.
      C E Modly, M Das, P S Don, C L Marcelo, H Mukhtar and D R Bickers
      Drug Metabolism and Disposition July 1986, 14 (4) 413-416;
  5. Dumont, P

    1. You have access
      Synthesis, characterization, and quantitation of para-hydroxymethadone, a metabolite of methadone in the rat.
      B M Gerardy, D Kapusta, P Dumont and J H Poupaert
      Drug Metabolism and Disposition July 1986, 14 (4) 477-481;

G

  1. Gerardy, B M

    1. You have access
      Synthesis, characterization, and quantitation of para-hydroxymethadone, a metabolite of methadone in the rat.
      B M Gerardy, D Kapusta, P Dumont and J H Poupaert
      Drug Metabolism and Disposition July 1986, 14 (4) 477-481;
  2. Gordon, W P

    1. You have access
      Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy, J S Lockard, K E Thummel and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 443-453;
    2. You have access
      Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 454-464;
  3. Gréen, K

    1. You have access
      Metabolism of 16, 16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester (ONO-802) following intravenous and vaginal administration to pregnant women.
      V Dimov, K Gréen, M Bygdeman and N J Christensen
      Drug Metabolism and Disposition July 1986, 14 (4) 494-502;
  4. Gross, B

    1. You have access
      Purification and identification of rat hepatic cytosolic enzymes responsible for defluorination of methoxyflurane and fluoroacetate.
      S L Wang, S A Rice, M T Serra and B Gross
      Drug Metabolism and Disposition July 1986, 14 (4) 392-398;
  5. Guengerich, F P

    1. You have access
      Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes.
      P H Beaune, P G Kremers, L S Kaminsky, J De Graeve, A Albert and F P Guengerich
      Drug Metabolism and Disposition July 1986, 14 (4) 437-442;

H

  1. Hawksworth, G M

    1. You have access
      Mechanism responsible for altered propranolol disposition in adjuvant-induced arthritis in the rat.
      K A Walker, H E Barber and G M Hawksworth
      Drug Metabolism and Disposition July 1986, 14 (4) 482-486;

J

  1. James, M O

    1. You have access
      Positional metabolism of benzo(a)pyrene in rat placenta and maternal liver. Comparison of induction effects.
      A S Salhab, M O James, S L Wang and K T Shiverick
      Drug Metabolism and Disposition July 1986, 14 (4) 471-476;

K

  1. Kaminsky, L S

    1. You have access
      Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes.
      P H Beaune, P G Kremers, L S Kaminsky, J De Graeve, A Albert and F P Guengerich
      Drug Metabolism and Disposition July 1986, 14 (4) 437-442;
  2. Kapusta, D

    1. You have access
      Synthesis, characterization, and quantitation of para-hydroxymethadone, a metabolite of methadone in the rat.
      B M Gerardy, D Kapusta, P Dumont and J H Poupaert
      Drug Metabolism and Disposition July 1986, 14 (4) 477-481;
  3. Kasuya, Y

    1. You have access
      Pharmacokinetic equivalence of deuterium-labeled and unlabeled phenytoin.
      K Mamada, Y Kasuya and S Baba
      Drug Metabolism and Disposition July 1986, 14 (4) 509-511;
  4. Kick, C J

    1. You have access
      Inhibition of ciramadol glucuronidation by benzodiazepines.
      R H Meacham, S F Sisenwine, A L Liu, C J Kick, I Barinov and H W Ruelius
      Drug Metabolism and Disposition July 1986, 14 (4) 430-436;
  5. Kolis, S J

    1. You have access
      Identification of trimoprostil metabolites excreted in rat bile formed by oxidation and taurine conjugation.
      S J Kolis, E J Postma, T H Williams and G J Sasso
      Drug Metabolism and Disposition July 1986, 14 (4) 465-470;
  6. Kremers, P G

    1. You have access
      Comparison of monooxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsomes.
      P H Beaune, P G Kremers, L S Kaminsky, J De Graeve, A Albert and F P Guengerich
      Drug Metabolism and Disposition July 1986, 14 (4) 437-442;
  7. Kumano, T

    1. You have access
      Comparative effect of chemical structure of chlorinated N-hydroxy-N-acyl-aminobiphenyl ethers and their related compounds on rat liver cytosol-catalyzed transacylation.
      T Kumano, T Yoshioka and T Uematsu
      Drug Metabolism and Disposition July 1986, 14 (4) 487-493;

L

  1. Levy, R H

    1. You have access
      Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy, J S Lockard, K E Thummel and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 443-453;
    2. You have access
      Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 454-464;
  2. Liu, A L

    1. You have access
      Inhibition of ciramadol glucuronidation by benzodiazepines.
      R H Meacham, S F Sisenwine, A L Liu, C J Kick, I Barinov and H W Ruelius
      Drug Metabolism and Disposition July 1986, 14 (4) 430-436;
  3. Lockard, J S

    1. You have access
      Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy, J S Lockard, K E Thummel and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 443-453;

M

  1. Mamada, K

    1. You have access
      Pharmacokinetic equivalence of deuterium-labeled and unlabeled phenytoin.
      K Mamada, Y Kasuya and S Baba
      Drug Metabolism and Disposition July 1986, 14 (4) 509-511;
  2. Marcelo, C L

    1. You have access
      Capsaicin as an in vitro inhibitor of benzo(a)pyrene metabolism and its DNA binding in human and murine keratinocytes.
      C E Modly, M Das, P S Don, C L Marcelo, H Mukhtar and D R Bickers
      Drug Metabolism and Disposition July 1986, 14 (4) 413-416;
  3. Meacham, R H

    1. You have access
      Inhibition of ciramadol glucuronidation by benzodiazepines.
      R H Meacham, S F Sisenwine, A L Liu, C J Kick, I Barinov and H W Ruelius
      Drug Metabolism and Disposition July 1986, 14 (4) 430-436;
  4. Mehendale, H M

    1. You have access
      In vitro metabolism of amiodarone by rabbit and rat liver and small intestine.
      R A Young and H M Mehendale
      Drug Metabolism and Disposition July 1986, 14 (4) 423-429;
  5. Modly, C E

    1. You have access
      Capsaicin as an in vitro inhibitor of benzo(a)pyrene metabolism and its DNA binding in human and murine keratinocytes.
      C E Modly, M Das, P S Don, C L Marcelo, H Mukhtar and D R Bickers
      Drug Metabolism and Disposition July 1986, 14 (4) 413-416;
  6. Mukhtar, H

    1. You have access
      Capsaicin as an in vitro inhibitor of benzo(a)pyrene metabolism and its DNA binding in human and murine keratinocytes.
      C E Modly, M Das, P S Don, C L Marcelo, H Mukhtar and D R Bickers
      Drug Metabolism and Disposition July 1986, 14 (4) 413-416;

N

  1. Nelson, W L

    1. You have access
      Stereoselective oxidative metabolism of propranolol in the microsomal fraction from rat and human liver. Use of deuterium labeling and pseudoracemic mixtures.
      W L Nelson and H U Shetty
      Drug Metabolism and Disposition July 1986, 14 (4) 506-508;

P

  1. Pathiratne, A

    1. You have access
      Activation of 14C-toluene to covalently binding metabolites by rat liver microsomes.
      A Pathiratne, R L Puyear and J D Brammer
      Drug Metabolism and Disposition July 1986, 14 (4) 386-391;
  2. Postma, E J

    1. You have access
      Identification of trimoprostil metabolites excreted in rat bile formed by oxidation and taurine conjugation.
      S J Kolis, E J Postma, T H Williams and G J Sasso
      Drug Metabolism and Disposition July 1986, 14 (4) 465-470;
  3. Poupaert, J H

    1. You have access
      Synthesis, characterization, and quantitation of para-hydroxymethadone, a metabolite of methadone in the rat.
      B M Gerardy, D Kapusta, P Dumont and J H Poupaert
      Drug Metabolism and Disposition July 1986, 14 (4) 477-481;
  4. Prickett, K S

    1. You have access
      Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy, J S Lockard, K E Thummel and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 443-453;
    2. You have access
      Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 454-464;
  5. Puyear, R L

    1. You have access
      Activation of 14C-toluene to covalently binding metabolites by rat liver microsomes.
      A Pathiratne, R L Puyear and J D Brammer
      Drug Metabolism and Disposition July 1986, 14 (4) 386-391;

R

  1. Rettenmeier, A W

    1. You have access
      Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy, J S Lockard, K E Thummel and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 443-453;
    2. You have access
      Biotransformation and pharmacokinetics in the rhesus monkey of 2-n-propyl-4-pentenoic acid, a toxic metabolite of valproic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 454-464;
  2. Rice, S A

    1. You have access
      Purification and identification of rat hepatic cytosolic enzymes responsible for defluorination of methoxyflurane and fluoroacetate.
      S L Wang, S A Rice, M T Serra and B Gross
      Drug Metabolism and Disposition July 1986, 14 (4) 392-398;
  3. Ruelius, H W

    1. You have access
      Inhibition of ciramadol glucuronidation by benzodiazepines.
      R H Meacham, S F Sisenwine, A L Liu, C J Kick, I Barinov and H W Ruelius
      Drug Metabolism and Disposition July 1986, 14 (4) 430-436;

S

  1. Salhab, A S

    1. You have access
      Positional metabolism of benzo(a)pyrene in rat placenta and maternal liver. Comparison of induction effects.
      A S Salhab, M O James, S L Wang and K T Shiverick
      Drug Metabolism and Disposition July 1986, 14 (4) 471-476;
  2. Sasso, G J

    1. You have access
      Identification of trimoprostil metabolites excreted in rat bile formed by oxidation and taurine conjugation.
      S J Kolis, E J Postma, T H Williams and G J Sasso
      Drug Metabolism and Disposition July 1986, 14 (4) 465-470;
  3. Schillings, R T

    1. You have access
      Disposition of (5H-dibenzo [a,d]cyclohepten-5-ylidene)acetic acid in laboratory animals.
      R T Schillings and S F Sisenwine
      Drug Metabolism and Disposition July 1986, 14 (4) 405-412;
  4. Serra, M T

    1. You have access
      Purification and identification of rat hepatic cytosolic enzymes responsible for defluorination of methoxyflurane and fluoroacetate.
      S L Wang, S A Rice, M T Serra and B Gross
      Drug Metabolism and Disposition July 1986, 14 (4) 392-398;
  5. Shetty, H U

    1. You have access
      Stereoselective oxidative metabolism of propranolol in the microsomal fraction from rat and human liver. Use of deuterium labeling and pseudoracemic mixtures.
      W L Nelson and H U Shetty
      Drug Metabolism and Disposition July 1986, 14 (4) 506-508;
  6. Shiverick, K T

    1. You have access
      Positional metabolism of benzo(a)pyrene in rat placenta and maternal liver. Comparison of induction effects.
      A S Salhab, M O James, S L Wang and K T Shiverick
      Drug Metabolism and Disposition July 1986, 14 (4) 471-476;
  7. Sisenwine, S F

    1. You have access
      Disposition of (5H-dibenzo [a,d]cyclohepten-5-ylidene)acetic acid in laboratory animals.
      R T Schillings and S F Sisenwine
      Drug Metabolism and Disposition July 1986, 14 (4) 405-412;
    2. You have access
      Inhibition of ciramadol glucuronidation by benzodiazepines.
      R H Meacham, S F Sisenwine, A L Liu, C J Kick, I Barinov and H W Ruelius
      Drug Metabolism and Disposition July 1986, 14 (4) 430-436;
  8. Smith, P C

    1. You have access
      Characterization of the isomeric esters of zomepirac glucuronide by proton NMR.
      P C Smith and L Z Benet
      Drug Metabolism and Disposition July 1986, 14 (4) 503-505;

T

  1. Thummel, K E

    1. You have access
      Metabolic fate of valproic acid in the rhesus monkey. Formation of a toxic metabolite, 2-n-propyl-4-pentenoic acid.
      A W Rettenmeier, W P Gordon, K S Prickett, R H Levy, J S Lockard, K E Thummel and T A Baillie
      Drug Metabolism and Disposition July 1986, 14 (4) 443-453;

U

  1. Uematsu, T

    1. You have access
      Comparative effect of chemical structure of chlorinated N-hydroxy-N-acyl-aminobiphenyl ethers and their related compounds on rat liver cytosol-catalyzed transacylation.
      T Kumano, T Yoshioka and T Uematsu
      Drug Metabolism and Disposition July 1986, 14 (4) 487-493;

W

  1. Walker, K A

    1. You have access
      Mechanism responsible for altered propranolol disposition in adjuvant-induced arthritis in the rat.
      K A Walker, H E Barber and G M Hawksworth
      Drug Metabolism and Disposition July 1986, 14 (4) 482-486;
  2. Wallace, K B

    1. You have access
      Aglycosylation and disposition of doxorubicin in isolated rat liver nuclei and microsomes.
      K B Wallace
      Drug Metabolism and Disposition July 1986, 14 (4) 399-404;
  3. Wang, S L

    1. You have access
      Purification and identification of rat hepatic cytosolic enzymes responsible for defluorination of methoxyflurane and fluoroacetate.
      S L Wang, S A Rice, M T Serra and B Gross
      Drug Metabolism and Disposition July 1986, 14 (4) 392-398;
    2. You have access
      Positional metabolism of benzo(a)pyrene in rat placenta and maternal liver. Comparison of induction effects.
      A S Salhab, M O James, S L Wang and K T Shiverick
      Drug Metabolism and Disposition July 1986, 14 (4) 471-476;
  4. Weber, W W

    1. You have access
      The molecular basis of hereditary acetylation polymorphisms.
      W W Weber
      Drug Metabolism and Disposition July 1986, 14 (4) 377-381;
    2. You have access
      N-acetylation pharmacogenetics. Michaelis-Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivo.
      H H Andres and W W Weber
      Drug Metabolism and Disposition July 1986, 14 (4) 382-385;
  5. Williams, T H

    1. You have access
      Identification of trimoprostil metabolites excreted in rat bile formed by oxidation and taurine conjugation.
      S J Kolis, E J Postma, T H Williams and G J Sasso
      Drug Metabolism and Disposition July 1986, 14 (4) 465-470;

Y

  1. Yoshioka, T

    1. You have access
      Comparative effect of chemical structure of chlorinated N-hydroxy-N-acyl-aminobiphenyl ethers and their related compounds on rat liver cytosol-catalyzed transacylation.
      T Kumano, T Yoshioka and T Uematsu
      Drug Metabolism and Disposition July 1986, 14 (4) 487-493;
  2. Young, R A

    1. You have access
      In vitro metabolism of amiodarone by rabbit and rat liver and small intestine.
      R A Young and H M Mehendale
      Drug Metabolism and Disposition July 1986, 14 (4) 423-429;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 14, Issue 4
1 Jul 1986
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Cannabinoid Metabolites as CYP450 Inhibitors
  • Physiology of the Neonatal Gastrointestinal System
  • Pharmacokinetics and Disposition of Biologics
  • Switch from CAR to PXR in the Presence of EGF
  • Alternative P450 Splicing Redirects Human Drug Metabolism
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics